• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

CPHD:US

54.2700 USD 0.0200 0.04%

As of 16:30:00 ET on 11/25/2014.

Snapshot for Cepheid (CPHD)

Open: 54.5900 Day's Range: 53.5200 - 54.7500 Volume: 371,112
Previous Close: 54.2500 52wk Range: 36.9400 - 55.8900 1-Yr Rtn: +21.44%

Stock Chart for CPHD

No chart data available.
  • CPHD:US 54.2500
  • 1D
  • 1M
  • 1Y
54.2500
Interactive CPHD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CPHD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 423.9844
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4609
Est. EPS (USD) (12/2014) 0.1280
Est. PEG Ratio 24.4724
Market Cap (M USD) 3,825.02
Shares Outstanding (M) 70.48
30 Day Average Volume 700,158
Price/Book (mrq) 10.5658
Price/Sale (ttm) 8.3408
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CPHD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CPHD

Cepheid, Inc. is a molecular diagnostics company dedicated to improving healthcare with its molecular systems and tests. The Company enables institutions to access the full power of molecular diagnostics with genetic testing for organisms and genetic-based diseases.

John L BishopChairman/CEOPhilippe JaconPresident:High Burden Dev
Andrew D MillerExec VP/CFOWarren C Kocmond JrExecutive VP/COO
More Company Profile & Key Executives for CPHD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • CPHD News

  • Industry News

No stories found
No stories found
Advertisement
Sponsored Links
Advertisements
sec ||= nil